Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cronos Group Inc (CRON) vs Jabil Inc (JBL) Price & Performance

Cronos Group IncTrade
Jabil IncTrade

Price performance (Past 24H)

Key statistics

Cronos Group Inc vs Jabil Inc — how do they compare? Cronos Group Inc trades at $2.74 (market cap $1.02B), while Jabil Inc trades at $329.01 (market cap $34.25B). The key difference: Jabil Inc is far larger — about 33.6× Cronos Group Inc's market cap, and Jabil Inc pays a 0.1% dividend while Cronos Group Inc pays none. Which is the better fit depends on your goals.

CRONJBL
Market Cap
$1.02B$34.25B
Sector
HealthTechnology
52-Week High
$3.27$385.50
52-Week Low
$1.95$192.49
Enterprise Value
$203.29M$36.78B
Dividend Yield
0.1%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cronos Group Inc

CRON trades at $2.75, showing no change recently. The stock has a mixed technical outlook with a neutral overall signal but bullish moving averages. Fundamentally, revenue grew to $146.59M in 2025, but net income was negative at -$9.45M. Recent news highlights strong Q1 2026 revenue growth of 40% and expansion of its Spinach brand portfolio, though the company faces intense cannabis sector competition.

Outlook is cautious with growth potential from international expansion and market share gains, but profitability remains a challenge. Risks include regulatory uncertainty and competitive pressures. Analyst sentiment is mixed with 60% hold ratings. The stock presents a speculative opportunity for investors betting on continued top-line growth and eventual margin improvement.

Jabil Inc

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

About Cronos Group Inc

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.

Read more on CRON

About Jabil Inc

Jabil is a global manufacturing solutions provider for industries including healthcare, automotive, and cloud. It offers comprehensive design, engineering, and supply chain management for complex electronic products.

Read more on JBL